These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 1346943

  • 1. Electrophysiological profile of the new atypical neuroleptic, sertindole, on midbrain dopamine neurones in rats: acute and repeated treatment.
    Skarsfeldt T.
    Synapse; 1992 Jan; 10(1):25-33. PubMed ID: 1346943
    [Abstract] [Full Text] [Related]

  • 2. Effect of the acute and chronic administration of the putative atypical antipsychotic drug Y-931 (8-fluoro-12- (4-methylpiperazin-1-yl)-6H-[1]benzothieno[2,3b][1,5] benzodiazepine maleate) on spontaneously active rat midbrain dopamine neurons: an in vivo electrophysiological study.
    Minabe Y, Hashimoto K, Shirayama Y, Ashby CR.
    Synapse; 2004 Jan; 51(1):19-26. PubMed ID: 14579422
    [Abstract] [Full Text] [Related]

  • 3. Differential effects after repeated treatment with haloperidol, clozapine, thioridazine and tefludazine on SNC and VTA dopamine neurones in rats.
    Skarsfeldt T.
    Life Sci; 1988 Jan; 42(10):1037-44. PubMed ID: 2894601
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Electrophysiological effects of BMY 14802, a new potential antipsychotic drug, on midbrain dopamine neurons in the rat: acute and chronic studies.
    Wachtel SR, White FJ.
    J Pharmacol Exp Ther; 1988 Jan; 244(1):410-6. PubMed ID: 2891845
    [Abstract] [Full Text] [Related]

  • 7. Effects of acute and repeated administration of amisulpride, a dopamine D2/D3 receptor antagonist, on the electrical activity of midbrain dopaminergic neurons.
    Di Giovanni G, Di Mascio M, Di Matteo V, Esposito E.
    J Pharmacol Exp Ther; 1998 Oct; 287(1):51-7. PubMed ID: 9765321
    [Abstract] [Full Text] [Related]

  • 8. Acute and chronic administration of the selective D(3) receptor antagonist SB-277011-A alters activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study.
    Ashby CR, Minabe Y, Stemp G, Hagan JJ, Middlemiss DN.
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1166-74. PubMed ID: 10945873
    [Abstract] [Full Text] [Related]

  • 9. Effect of acute and chronic administration of the selective 5-HT2C receptor antagonist SB-243213 on midbrain dopamine neurons in the rat: an in vivo extracellular single cell study.
    Blackburn TP, Minabe Y, Middlemiss DN, Shirayama Y, Hashimoto K, Ashby CR.
    Synapse; 2002 Dec 01; 46(3):129-39. PubMed ID: 12325040
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of chronic treatment with SCH 23390 and haloperidol on spontaneous activity of dopamine neurones in substantia nigra pars compacta (SNC) and ventral tegmental area (VTA) in rats.
    Skarsfeldt T.
    Eur J Pharmacol; 1988 Jan 12; 145(2):239-43. PubMed ID: 3280330
    [Abstract] [Full Text] [Related]

  • 12. Stimulation of serotonin2C receptors blocks the hyperactivation of midbrain dopamine neurons induced by nicotine administration.
    Pierucci M, Di Matteo V, Esposito E.
    J Pharmacol Exp Ther; 2004 Apr 12; 309(1):109-18. PubMed ID: 14722316
    [Abstract] [Full Text] [Related]

  • 13. CI-943, a potential antipsychotic agent. III. Evaluation of effects on dopamine neuronal activity.
    Meltzer LT, Christoffersen CL, Heffner TG, Freeman AS, Chiodo LA.
    J Pharmacol Exp Ther; 1989 Oct 12; 251(1):123-30. PubMed ID: 2571714
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The effect of the acute and chronic administration of CP 96,345, a selective neurokinin1 receptor antagonist, on midbrain dopamine neurons in the rat: a single unit, extracellular recording study.
    Minabe Y, Emori K, Toor A, Stutzmann GE, Ashby CR.
    Synapse; 1996 Jan 12; 22(1):35-45. PubMed ID: 8822476
    [Abstract] [Full Text] [Related]

  • 16. The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in rats.
    Okuyama S, Chaki S, Kawashima N, Suzuki Y, Ogawa S, Kumagai T, Nakazato A, Nagamine M, Yamaguchi K, Tomisawa K.
    Br J Pharmacol; 1997 Jun 12; 121(3):515-25. PubMed ID: 9179395
    [Abstract] [Full Text] [Related]

  • 17. Acute and chronic administration of the selective 5-HT1A receptor antagonist WAY-405 significantly alters the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study.
    Minabe Y, Schechter L, Hashimoto K, Shirayama Y, Ashby CR.
    Synapse; 2003 Dec 01; 50(3):181-90. PubMed ID: 14515335
    [Abstract] [Full Text] [Related]

  • 18. Acute and chronic administration of the selective sigma1 receptor agonist SA4503 significantly alters the activity of midbrain dopamine neurons in rats: An in vivo electrophysiological study.
    Minabe Y, Matsuno K, Ashby CR.
    Synapse; 1999 Aug 01; 33(2):129-40. PubMed ID: 10400891
    [Abstract] [Full Text] [Related]

  • 19. Differential modulation by nicotine of substantia nigra versus ventral tegmental area dopamine neurons.
    Keath JR, Iacoviello MP, Barrett LE, Mansvelder HD, McGehee DS.
    J Neurophysiol; 2007 Dec 01; 98(6):3388-96. PubMed ID: 17942622
    [Abstract] [Full Text] [Related]

  • 20. Comparison of short-term administration of sertindole, clozapine and haloperidol on the inactivation of midbrain dopamine neurons in the rat.
    Skarsfeldt T.
    Eur J Pharmacol; 1994 Mar 21; 254(3):291-4. PubMed ID: 7912200
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.